Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Exact Sciences Corp (EXAS) since 2001 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Exact Sciences Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1124140.
Total stock buying since 2001: $1,792,411.
Total stock sales since 2001: $327,519,821.
Total stock option exercises since 2001: $31,007,777.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 4,692 | $233,011 | 192,859 | $1,493,260 |
| 2024 | 19,500 | $1,001,325 | 106,368 | $6,444,968 | 252,334 | $1,435,604 |
| 2023 | 0 | $0 | 152,617 | $10,776,985 | 180,827 | $90,480 |
| 2022 | 0 | $0 | 123,980 | $8,214,810 | 696,995 | $14,410,352 |
| 2021 | 0 | $0 | 472,513 | $59,803,671 | 302,420 | $2,613,303 |
| 2020 | 0 | $0 | 370,067 | $36,422,904 | 204,388 | $3,203,683 |
| 2019 | 0 | $0 | 899,722 | $77,172,301 | 1,065,274 | $499,480 |
| 2018 | 0 | $0 | 912,540 | $51,810,433 | 810,073 | $1,235,546 |
| 2017 | 2,500 | $94,275 | 927,800 | $46,534,212 | 950,185 | $2,726,466 |
| 2016 | 92,155 | $696,811 | 1,527,810 | $26,291,768 | 2,436,900 | $3,190,873 |
| 2015 | 0 | $0 | 81,727 | $1,976,888 | 329,423 | $108,730 |
| 2014 | 0 | $0 | 0 | $0 | 33,601 | $0 |
| 2001 | 0 | $0 | 17,000 | $1,837,870 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-31 | Carey Thomas D. (Director) | Option Ex | 15,620 | 9.24 | 144,328 |
| 2020-07-31 | Zanotti Katherine S (Director) | Sale | 21,029 | 94.00 | 1,976,726 |
| 2020-07-31 | Zanotti Katherine S (Director) | Option Ex | 21,029 | 8.52 | 179,167 |
| 2020-07-31 | Levangie Daniel J (Director) | Sale | 9,865 | 94.00 | 927,310 |
| 2020-07-31 | Levangie Daniel J (Director) | Option Ex | 9,865 | 9.35 | 92,237 |
| 2020-07-29 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 8,746 | 95.58 | 835,942 |
| 2020-07-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 18,750 | 94.81 | 1,777,687 |
| 2020-07-28 | Zanotti Katherine S (Director) | Sale | 1,164 | 96.13 | 111,895 |
| 2020-04-03 | Stenhouse Mark (President, Cologuard) | Sale | 11,948 | 56.69 | 677,332 |
| 2020-04-02 | Stenhouse Mark (President, Cologuard) | Option Ex | 25,000 | .00 | 0 |
| 2020-02-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 2,383 | 80.17 | 191,045 |
| 2020-02-28 | Doyle James Edward (Director) | Sale | 2,000 | 77.54 | 155,080 |
| 2020-02-28 | Conroy Kevin T (President and CEO) | Sale | 9,750 | 80.17 | 781,657 |
| 2020-02-27 | Stenhouse Mark (President, Cologuard) | Sale | 1,051 | 80.27 | 84,363 |
| 2020-02-27 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 1,627 | 80.27 | 130,599 |
| 2020-02-27 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 5,025 | .00 | 0 |
| 2020-02-27 | Conroy Kevin T (President and CEO) | Option Ex | 20,575 | .00 | 0 |
| 2020-02-26 | Stenhouse Mark (President, Cologuard) | Option Ex | 3,262 | .00 | 0 |
| 2020-02-26 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 3,436 | .00 | 0 |
| 2020-02-25 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 4,910 | 85.11 | 417,890 |
| 2020-02-25 | Conroy Kevin T (President and CEO) | Sale | 18,115 | 85.11 | 1,541,767 |
| 2020-02-24 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 9,300 | .00 | 0 |
| 2020-02-24 | Conroy Kevin T (President and CEO) | Option Ex | 34,325 | .00 | 0 |
| 2020-02-19 | Cole G Bradley (General Manager - Diagnostics) | Sale | 27,356 | 100.00 | 2,735,600 |
| 2020-02-19 | Cole G Bradley (General Manager - Diagnostics) | Option Ex | 17,356 | 35.59 | 617,786 |
| 2020-02-19 | Orville Jacob A (General Manager, New Ventures) | Sale | 1,153 | 100.68 | 116,084 |
| 2020-02-18 | Orville Jacob A (General Manager, New Ventures) | Option Ex | 3,648 | .00 | 0 |
| 2020-02-15 | Hoof Torsten (General Manager, International) | Option Ex | 2,091 | .00 | 0 |
| 2020-01-16 | Cole G Bradley (General Manager - Diagnostics) | Sale | 10,000 | 90.30 | 903,000 |
| 2019-12-16 | Conroy Kevin T (President and CEO) | Option Ex | 11,440 | 18.67 | 213,584 |
| 2019-11-21 | Cole G Bradley (General Manager - Diagnostics) | Sale | 28,016 | 80.38 | 2,251,926 |
| 2019-09-12 | Johnson Scott C. (SVP - Research and Development) | Sale | 3,527 | 108.63 | 383,138 |
| 2019-09-11 | Johnson Scott C. (SVP - Research and Development) | Option Ex | 7,500 | .00 | 0 |
| 2019-07-31 | Doyle James Edward (Director) | Sale | 2,808 | 117.93 | 331,147 |
| 2019-07-31 | Carey Thomas D. (Director) | Sale | 10,000 | 117.65 | 1,176,520 |
| 2019-07-31 | Zanotti Katherine S (Director) | Sale | 1,744 | 117.93 | 205,669 |
| 2019-07-31 | Wyzga Michael S (Director) | Sale | 5,000 | 117.93 | 589,650 |
| 2019-07-31 | Wyzga Michael S (Director) | Option Ex | 2,500 | 26.98 | 67,450 |
| 2019-07-31 | Levangie Daniel J (Director) | Sale | 42,607 | 117.61 | 5,011,009 |
| 2019-07-31 | Levangie Daniel J (Director) | Option Ex | 42,607 | 5.13 | 218,446 |
| 2019-07-30 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 9,845 | 105.60 | 1,039,632 |
| 2019-07-29 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 18,750 | .00 | 0 |
| 2019-04-03 | Stenhouse Mark (President, Cologuard) | Sale | 11,192 | 92.54 | 1,035,696 |
| 2019-04-02 | Stenhouse Mark (President, Cologuard) | Option Ex | 25,000 | .00 | 0 |
| 2019-03-11 | Conroy Kevin T (President and CEO) | Sale | 11,227 | 87.21 | 979,129 |
| 2019-03-11 | Coward D Scott (Chief Administrative Officer) | Sale | 2,774 | 87.21 | 241,926 |
| 2019-03-09 | Conroy Kevin T (President and CEO) | Option Ex | 24,400 | .00 | 0 |
| 2019-03-09 | Coward D Scott (Chief Administrative Officer) | Option Ex | 6,025 | .00 | 0 |
| 2019-02-28 | Johnson Scott C. (SVP - Research and Development) | Sale | 1,166 | 93.20 | 108,675 |
| 2019-02-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 2,447 | 93.20 | 228,070 |
| 2019-02-28 | Doyle James Edward (Director) | Sale | 2,000 | 96.00 | 192,000 |
| 2019-02-28 | Carey Thomas D. (Director) | Sale | 7,500 | 96.00 | 720,000 |
| 2019-02-28 | Zanotti Katherine S (Director) | Sale | 25,000 | 93.74 | 2,343,450 |
| 2019-02-28 | Conroy Kevin T (President and CEO) | Sale | 10,014 | 93.20 | 933,344 |
| 2019-02-28 | Coward D Scott (Chief Administrative Officer) | Sale | 2,447 | 93.20 | 228,070 |
| 2019-02-28 | Wyzga Michael S (Director) | Sale | 500 | 96.00 | 48,000 |
| 2019-02-27 | Johnson Scott C. (SVP - Research and Development) | Option Ex | 3,525 | .00 | 0 |
| 2019-02-27 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 5,025 | .00 | 0 |
| 2019-02-27 | Conroy Kevin T (President and CEO) | Sale | 9,169 | 95.07 | 871,733 |
| 2019-02-27 | Conroy Kevin T (President and CEO) | Option Ex | 20,575 | .00 | 0 |
| 2019-02-27 | Coward D Scott (Chief Administrative Officer) | Sale | 9,803 | 95.07 | 932,010 |
| 2019-02-27 | Coward D Scott (Chief Administrative Officer) | Option Ex | 5,025 | .00 | 0 |
| 2019-02-26 | Conroy Kevin T (President and CEO) | Option Ex | 20,025 | .00 | 0 |
| 2019-02-26 | Coward D Scott (Chief Administrative Officer) | Option Ex | 21,400 | .00 | 0 |
| 2019-02-25 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 13,335 | 90.55 | 1,207,497 |
| 2019-02-25 | Conroy Kevin T (President and CEO) | Sale | 49,200 | 90.55 | 4,455,108 |
| 2019-02-25 | Coward D Scott (Chief Administrative Officer) | Sale | 18,429 | 90.55 | 1,668,762 |
| 2019-02-23 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 27,900 | .00 | 0 |
| 2019-02-23 | Conroy Kevin T (President and CEO) | Option Ex | 102,975 | .00 | 0 |
| 2019-02-23 | Coward D Scott (Chief Administrative Officer) | Option Ex | 38,550 | .00 | 0 |
| 2019-01-25 | Conroy Kevin T (President and CEO) | Sale | 304,397 | 80.77 | 24,586,754 |
| 2019-01-24 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 90,909 | 78.56 | 7,141,538 |
| 2019-01-24 | Conroy Kevin T (President and CEO) | Option Ex | 304,397 | .00 | 0 |
| 2019-01-24 | Coward D Scott (Chief Administrative Officer) | Sale | 169,109 | 78.50 | 13,275,056 |
| 2019-01-23 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 90,909 | .00 | 0 |
| 2019-01-23 | Coward D Scott (Chief Administrative Officer) | Option Ex | 169,109 | .00 | 0 |
| 2019-01-03 | Coward D Scott (Chief Administrative Officer) | Sale | 1,581 | 62.75 | 99,214 |
| 2019-01-02 | Coward D Scott (Chief Administrative Officer) | Option Ex | 4,687 | .00 | 0 |
| 2018-11-12 | Zanotti Katherine S (Director) | Sale | 7,667 | 69.00 | 529,023 |
| 2018-11-12 | Zanotti Katherine S (Director) | Option Ex | 7,667 | 3.43 | 26,297 |
| 2018-11-12 | Conroy Kevin T (President and CEO) | Sale | 163,514 | 69.00 | 11,282,466 |
| 2018-11-12 | Conroy Kevin T (President and CEO) | Option Ex | 163,514 | .83 | 135,716 |
| 2018-11-07 | Lidgard Graham Peter (Chief Science Officer) | Sale | 698 | 75.01 | 52,356 |
| 2018-11-05 | Lidgard Graham Peter (Chief Science Officer) | Sale | 37,613 | 75.01 | 2,821,275 |
| 2018-11-01 | Lidgard Graham Peter (Chief Science Officer) | Sale | 57,517 | 70.88 | 4,076,747 |
| 2018-10-31 | Lidgard Graham Peter (Chief Science Officer) | Sale | 22,156 | 75.35 | 1,669,498 |
| 2018-10-08 | Lidgard Graham Peter (Chief Science Officer) | Sale | 58,000 | 69.26 | 4,017,254 |
| 2018-10-01 | Coward D Scott (Chief Administrative Officer) | Sale | 2,190 | 79.51 | 174,118 |
| 2018-09-30 | Coward D Scott (Chief Administrative Officer) | Option Ex | 4,688 | .00 | 0 |
| 2018-08-28 | Wyzga Michael S (Director) | Sale | 2,468 | 74.85 | 184,729 |
| 2018-07-30 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 8,984 | 57.78 | 519,095 |
| 2018-07-30 | Doyle James Edward (Director) | Sale | 1,318 | 58.86 | 77,577 |
| 2018-07-30 | Carey Thomas D. (Director) | Sale | 3,427 | 58.86 | 201,713 |
| 2018-07-30 | Fallon John A. (Director) | Sale | 2,373 | 58.86 | 139,674 |
| 2018-07-30 | Zanotti Katherine S (Director) | Sale | 2,847 | 58.86 | 167,574 |
| 2018-07-28 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 18,750 | .00 | 0 |
| 2018-05-10 | Wyzga Michael S (Director) | Sale | 7,402 | 51.53 | 381,447 |
| 2018-04-12 | Zanotti Katherine S (Director) | Sale | 7,232 | 45.00 | 325,440 |
| 2018-04-10 | Doyle James Edward (Director) | Sale | 3,098 | 40.97 | 126,925 |
| 2018-04-10 | Carey Thomas D. (Director) | Sale | 8,448 | 40.27 | 340,200 |
| 2018-04-02 | Coward D Scott (SVP and General Counsel) | Sale | 2,122 | 40.12 | 85,124 |
| 2018-03-31 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,688 | .00 | 0 |
| 2018-03-14 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 7,163 | 13.96 | 99,995 |
| 2018-03-13 | Lidgard Graham Peter (Chief Science Officer) | Sale | 4,464 | 53.21 | 237,529 |
| 2018-03-12 | Conroy Kevin T (President and CEO) | Sale | 11,459 | 52.19 | 598,091 |
| 2018-03-12 | Arora Maneesh (COO) | Sale | 5,295 | 52.19 | 276,367 |
| 2018-03-12 | Coward D Scott (SVP and General Counsel) | Sale | 2,708 | 52.19 | 141,341 |
| 2018-03-12 | Lidgard Graham Peter (Chief Science Officer) | Sale | 3,961 | 52.19 | 206,740 |
| 2018-03-09 | Conroy Kevin T (President and CEO) | Option Ex | 24,400 | .00 | 0 |
| 2018-03-09 | Arora Maneesh (COO) | Option Ex | 11,275 | .00 | 0 |
| 2018-03-09 | Coward D Scott (SVP and General Counsel) | Option Ex | 6,025 | .00 | 0 |
| 2018-03-09 | Lidgard Graham Peter (Chief Science Officer) | Sale | 6,125 | 50.94 | 312,001 |
| 2018-03-09 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 14,550 | 11.69 | 170,089 |
| 2018-02-27 | Conroy Kevin T (President and CEO) | Sale | 9,085 | 44.10 | 400,630 |
| 2018-02-27 | Arora Maneesh (COO) | Sale | 5,512 | 44.10 | 243,068 |
| 2018-02-27 | Lidgard Graham Peter (Chief Science Officer) | Sale | 16,688 | 43.77 | 730,500 |
| 2018-02-26 | Elliott Jeffrey Thomas (Chief Financial Officer) | Sale | 2,982 | 42.34 | 126,251 |
| 2018-02-26 | Conroy Kevin T (President and CEO) | Sale | 25,319 | 42.34 | 1,071,955 |
| 2018-02-26 | Conroy Kevin T (President and CEO) | Option Ex | 20,025 | .00 | 0 |
| 2018-02-26 | Arora Maneesh (COO) | Sale | 12,352 | 42.34 | 522,958 |
| 2018-02-26 | Arora Maneesh (COO) | Option Ex | 12,150 | .00 | 0 |
| 2018-02-26 | Coward D Scott (SVP and General Counsel) | Sale | 4,420 | 42.34 | 187,133 |
| 2018-02-26 | Lidgard Graham Peter (Chief Science Officer) | Sale | 25,515 | 42.30 | 1,078,805 |
| 2018-02-26 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 27,237 | 6.55 | 178,484 |
| 2018-02-24 | Conroy Kevin T (President and CEO) | Option Ex | 19,500 | .00 | 0 |
| 2018-02-24 | Arora Maneesh (COO) | Option Ex | 11,000 | .00 | 0 |
| 2018-02-24 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 8,250 | .00 | 0 |
| 2018-02-23 | Elliott Jeffrey Thomas (Chief Financial Officer) | Option Ex | 9,300 | .00 | 0 |
| 2018-02-23 | Conroy Kevin T (President and CEO) | Option Ex | 34,325 | .00 | 0 |
| 2018-02-23 | Arora Maneesh (COO) | Option Ex | 18,875 | .00 | 0 |
| 2018-02-23 | Coward D Scott (SVP and General Counsel) | Option Ex | 12,850 | .00 | 0 |
| 2018-02-23 | Lidgard Graham Peter (Chief Science Officer) | Sale | 20,250 | 39.90 | 808,056 |
| 2018-02-23 | Lidgard Graham Peter (Chief Science Officer) | Option Ex | 31,825 | 10.84 | 344,983 |
| 2018-02-09 | Conroy Kevin T (President and CEO) | Sale | 101,488 | 45.81 | 4,649,165 |
| 2018-02-09 | Conroy Kevin T (President and CEO) | Option Ex | 101,488 | .83 | 84,235 |
| 2018-01-23 | Conroy Kevin T (President and CEO) | Sale | 110,439 | 50.20 | 5,543,816 |
| 2018-01-23 | Conroy Kevin T (President and CEO) | Option Ex | 110,439 | .83 | 91,664 |
| 2018-01-12 | Conroy Kevin T (President and CEO) | Sale | 125,402 | 52.96 | 6,641,415 |
| 2018-01-12 | Conroy Kevin T (President and CEO) | Option Ex | 125,402 | .83 | 104,083 |
| 2018-01-03 | Coward D Scott (SVP and General Counsel) | Sale | 1,665 | 52.54 | 87,474 |
| 2018-01-02 | Coward D Scott (SVP and General Counsel) | Option Ex | 4,687 | .00 | 0 |
| 2017-12-22 | Conroy Kevin T (President and CEO) | Sale | 123,512 | 52.86 | 6,529,091 |
| 2017-12-22 | Conroy Kevin T (President and CEO) | Option Ex | 123,512 | .83 | 102,514 |
| 2017-12-06 | Conroy Kevin T (President and CEO) | Sale | 121,849 | 53.58 | 6,528,182 |
| 2017-12-06 | Conroy Kevin T (President and CEO) | Option Ex | 121,849 | .83 | 101,134 |
| 2017-12-01 | Lidgard Graham Peter (Chief Science Officer) | Sale | 45,770 | 58.31 | 2,668,940 |
| 2017-11-21 | Conroy Kevin T (President and CEO) | Sale | 134,057 | 59.50 | 7,976,659 |
| 2017-11-21 | Conroy Kevin T (President and CEO) | Option Ex | 134,057 | .83 | 111,267 |
| 2017-11-09 | Conroy Kevin T (President and CEO) | Sale | 137,805 | 59.36 | 8,179,691 |
| 2017-11-09 | Conroy Kevin T (President and CEO) | Option Ex | 137,815 | .83 | 114,386 |
Insider trading activities including stock purchases, stock sales, and option exercises of EXAS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Exact Sciences Corp (symbol EXAS, CIK number 1124140) see the Securities and Exchange Commission (SEC) website.